Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $554.66M≈ (-$96M≈)
- Previous value:
- $651.15M≈
- # of changes:
- 26
- New positions:
- 0
- Reported for:
- 31 Dec 2018 (Q4)
- Latest filing date:
- 29 Jan 2019
Kahn Brothers Group has disclosed a total of 26 changes to the portfolio in the (2018 Q4) SEC report(s): increased the number of shares of 6 and decreased the number of shares of 20 position(s).
What stocks did Kahn Brothers Group buy in 2018 Q4?
During 2018 Q4 Kahn Brothers Group has bought 6 securities out of which top 5 purchases (by % change to portfolio) were (C) Citigroup Inc (added shares +1.94%), (GSK) GlaxoSmithKline PLC ADR (added shares +1.56%), (FLG) Flagstar Financial, Inc (added shares +9.50%), (BB) BlackBerry Ltd (added shares +0.32%) and (PTEN) Patterson-UTI Energy Inc (added shares +17.33%).
In the 2018 Q4 report(s) the following changes have been made to the top investments: (MRK) Merck & Company Inc (reduced shares -0.90%), (BP) BP PLC-SPONS ADR (reduced shares -0.29%), (C) Citigroup Inc (added shares +1.94%), (AGO) ASSURED GUARANTY LTD (reduced shares -0.75%) and (GSK) GlaxoSmithKline PLC ADR (added shares +1.56%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.